Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 2:53 pm Sale | 2023-12-31 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | ARMISTICE CAPITAL LLC | 163,100 4.990% | -81,899 (-33.43%) | Filing History |
| 2024-02-13 8:09 pm Purchase | 2023-12-31 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | Lind Global Fund II LP | 125,520 3.900% | 125,520 (New Position) | Filing History |
| 2024-02-06 12:08 pm Sale | 2024-02-05 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | Foose Brice | 0 0.000% | -330,000 (Position Closed) | Filing History |
| 2023-04-25 5:37 pm Purchase | 2023-04-20 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | Foose Brice | 330,000 11.500% | 330,000 (New Position) | Filing History |
| 2023-02-14 1:13 pm Purchase | 2022-12-31 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | ARMISTICE CAPITAL LLC | 244,999 9.990% | 244,999 (New Position) | Filing History |
| 2023-02-13 4:25 pm Purchase | 2022-12-31 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | Lind Global Macro Fund LP | 128,321 6.300% | 128,321 (New Position) | Filing History |
| 2022-02-11 07:24 am Sale | 2021-12-31 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | Mitchell P. Kopin | 34,597 2.500% | -27,631 (-44.40%) | Filing History |
| 2022-02-09 5:02 pm Purchase | 2021-12-31 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | Lind Global Macro Fund LP | 125,520 8.400% | 34,759 (+38.30%) | Filing History |
| 2021-02-16 10:02 am Purchase | 2020-12-31 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | CVI Investments, Inc. | 40,748 4.800% | 22,462 (+122.84%) | Filing History |
| 2021-02-09 4:46 pm Sale | 2020-12-31 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | L1 Capital Global Opportunities Master Fund, Ltd. | 42,450 4.800% | -42,450 (-50.00%) | Filing History |
| 2021-02-03 4:33 pm Sale | 2020-12-31 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | BIGGER CAPITAL FUND L P | 15,500 11.000% | -39,500 (-71.82%) | Filing History |
| 2021-01-29 06:23 am Purchase | 2020-12-31 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | Mitchell P. Kopin | 62,229 6.800% | 50,000 (+408.88%) | Filing History |
| 2021-01-20 4:31 pm Purchase | 2020-12-31 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | Lind Global Macro Fund LP | 90,761 9.900% | 26,151 (+40.48%) | Filing History |
| 2021-01-05 3:43 pm Purchase | 2020-12-31 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | SABBY MANAGEMENT LLC | 42,259 11.000% | 23,211 (+121.86%) | Filing History |
| 2020-11-02 5:29 pm Purchase | 2020-10-23 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | BIGGER CAPITAL FUND L P | 55,000 5.800% | 55,000 (New Position) | Filing History |
| 2020-11-02 4:10 pm Purchase | 2020-10-22 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | L1 Capital Global Opportunities Master Fund, Ltd. | 84,900 8.600% | 84,900 (New Position) | Filing History |
| 2020-10-23 4:38 pm Purchase | 2020-10-22 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | Lind Global Macro Fund LP | 64,610 9.900% | 64,610 (New Position) | Filing History |
| 2020-04-24 5:04 pm Purchase | 2020-04-15 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | ARMISTICE CAPITAL LLC | 10,184 4.990% | 5,729 (+128.59%) | Filing History |
| 2020-04-24 4:14 pm Purchase | 2020-04-15 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | Mitchell P. Kopin | 12,229 5.900% | 12,229 (New Position) | Filing History |
| 2020-04-24 11:18 am Purchase | 2020-04-15 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ | CVI Investments, Inc. | 18,286 9.400% | 18,286 (New Position) | Filing History |